AstraZeneca announced forecast-beating revenue on Tuesday. AstraZeneca's chief executive on Tuesday teased the prospect of a weight-loss drug in development that the company moved into late-stage ...

LONDON — The head of drug maker AstraZeneca will retire next month, the company said. The Anglo-Swedish drug manufacturer announced the planned retirement of CEO and board member David Brennan, ...

Pascal Soriot, Chief Executive Officer, AstraZeneca, said: "In 2025 we saw strong commercial performance across our therapy areas and excellent pipeline delivery. We announced the results of 16 ...

LONDON, Jan 26 (Reuters) - UK-headquartered pharmaceutical firm AstraZeneca's CEO Pascal Soriot will join Prime Minister Keir Starmer's trip to China this week, said a source familiar with the matter, ...

Another phase 3 trial, Chestnut, evaluated children who switched from Strensiq to efzimfotase alfa. The study showed ...

AstraZeneca’s chief executive on Tuesday teased the prospect of a weight-loss drug in development that the company moved into late-stage trials. The company said it’s starting a Phase III program on ...